EMIS is now Optum.Find out more here.

iPLATO

Key benefits

  •   Digital solutions to improve access to primary care and reduce pressure on A&E.
  •   Intelligent insight to implement long-lasting improvements.
  •   Healthcare initiatives that increase patient engagement and inclusion.

Improving health outcomes and access to primary care

iPLATO service (also resold by EE, part of the BT Group, and is the UK's most advanced digital communications company) improves health outcomes and transforms access to primary care.

iPLATO, is an IGSoC compliant web-based service that is securely hosted within N3. The platform uses the NFC8 Tier 1 NHS approved UK Government procured gateway to combine safety and security with the lowest transaction costs in the market.

A focus on improving the clinical environment

iPLATO includes a Patient Facing Service called myGP, developed under the nationally funded GPSoC Lot 1 (free for patients, practices and CCGs). This ‘must-have’ healthcare app helps GP practices comply with national guidelines for online patient services, whilst offering specific improvements in automated data collection, streamlined call and recall, and improved medication management that support digital care plans.

The iPLATO solution supports true ‘2-way’ text messaging to allow GP patients to cancel unwanted appointments through reply SMS (in response to an automated appointment reminder) or through myGP. This allows GP practices to systematically free up urgent GP appointments, thereby, improving access and reducing pressure on local A&E. The service also includes a sophisticated Campaign Read Coding feature too.

If you would like to find out more about iPLATO or have any questions, please contact us below. Please note all enquires will be forwarded to the partner and will not be responded to by Optum (formerly EMIS).
Have Any Questions Contact Form 1 1

Have any questions about iPLATO? Get in touch

Sign up for our monthly newsletter.